Who invested in Focal Therapeutics?
Focal Therapeutics's investors include Okapi Venture Capital and Emergent Medical Partners.
United States · Series C startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Focal Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$3.5Mraised across 1 round since 2014, from 1 source
From a historical funding recordSEC filing: $7.8M sold, first sale Aug 2013
Focal Therapeutics's investors include Okapi Venture Capital and Emergent Medical Partners.
Focal Therapeutics has raised $3.5M across 1 round since 2014.
Focal Therapeutics's most recent round was a Series C of $3.5M in Aug 2014.
Its most recent round, $3.5M in Aug 2014, is also its largest on record.
Focal Therapeutics's first round on record, in Aug 2014, was backed by Okapi Venture Capital and Emergent Medical Partners.
Focal Therapeutics's latest named round is a Series C, in Aug 2014.
Focal Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.